Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. RepliCel Life Sciences Inc.
  6. Financials
    REPCF   CA76027P4006

REPLICEL LIFE SCIENCES INC.

(REPCF)
Delayed OTC Markets  -  11:56 2022-06-24 am EDT
0.1005 USD   +16.59%
06/17REPLICEL LIFE SCIENCES : PROVIDES DEFAULT STATUS UPDATE - Form 6-K
PU
06/02REPLICEL LIFE SCIENCES : PROVIDES DEFAULT STATUS UPDATE - Form 6-K
PU
03/29REPLICEL LIFE SCIENCES : 51-102F3 MATERIAL CHANGE REPORT - Form 6-K
PU
SummaryQuotesChartsNewsCalendarCompanyFinancials 
Valuation
Fiscal Period: December 2015 2016 2017 2018 2019 2020
Capitalization1 16,914,28,409,658,747,26
Enterprise Value (EV)1 16,914,28,409,659,147,80
P/E ratio -3,01x-1,78x-1,21x-2,83x-2,29x-3,69x
Yield ------
Capitalization / Revenue ---57 561 954x24 719 357x20 516 305x
EV / Revenue ---57 561 954x24 719 358x20 516 306x
EV / EBITDA -3,36x-3,33x-1,40x-3,58x-2,99x-5,38x
Price to Book -----1,59x-1,28x
Nbr of stocks (in thousands) 6 34814 93821 54326 80030 64633 523
Reference price (CAD) 2,670,950,390,360,290,22
Announcement Date 04/30/201804/30/201912/22/202004/30/202104/30/202104/30/2021
1 USD in Million
Income Statement Evolution (Annual data)
Fiscal Period: December 2015 2016 2017 2018 2019 2020
Net sales ---0,170,350,35
EBITDA1 -5,04-4,28-5,99-2,69-2,92-1,35
Operating profit (EBIT)1 -5,05-4,29-5,99-2,70-2,93-1,35
Operating Margin ----1 609%-827%-382%
Pre-Tax Profit (EBT)1 -5,04-4,27-6,01-2,78-3,00-1,58
Net income1 -5,04-4,27-6,01-2,78-3,00-1,58
Net margin ----1 660%-849%-447%
EPS2 -0,89-0,54-0,32-0,13-0,12-0,06
Dividend per Share ------
Announcement Date 04/30/201804/30/201912/22/202004/30/202104/30/202104/30/2021
1 CAD in Million
2 CAD
Balance Sheet Analysis
Fiscal Period: December 2015 2016 2017 2018 2019 2020
Net Debt ----0,400,54
Net Cash position ------
Leverage (Debt / EBITDA) -----0,14x-0,40x
Free Cash Flow1 -2,47-1,99-3,12-1,15-1,94-0,26
ROE (Net Profit / Equities) -838%-1 413%-1 357%251%95,0%33,3%
Shareholders' equity1 0,600,300,44-1,11-3,16-4,74
ROA (Net Profit / Asset) -247%-239%-280%-80,9%-95,5%-182%
Assets1 2,041,792,153,443,140,87
Book Value Per Share -----0,18-0,17
Cash Flow per Share ----0,000,00
Capex1 0,00-----
Capex / Sales ------
Announcement Date 04/30/201804/30/201912/22/202004/30/202104/30/202104/30/2021
1 CAD in Million
Key data
Capitalization (USD) 4 696 993
Net sales (CAD) 353 735
Net sales (USD) 273 852
Number of employees 1
Sales / Employee (CAD) 353 735
Sales / Employee (USD) 273 852
Free-Float 62,3%
Free-Float capitalization (USD) 2 926 181
Avg. Exchange 20 sessions (CAD) 209
Avg. Exchange 20 sessions (USD) 162
Average Daily Capital Traded 0,00%
EPS & Dividend